Abstract. The lack of rapid, affordable, and accurate diagnostic tests represents the primary hurdle affecting malaria surveillance in resource-and expertise-limited areas. Loop-mediated isothermal amplification (LAMP) is a sensitive, rapid, and cheap diagnostic method. Five species-specific LAMP assays were developed based on 18S rRNA gene. Sensitivity and specificity of LAMP results were calculated as compared with microscopic examination and nested polymerase chain reaction. LAMP reactions were highly sensitive with the detection limit of one copy for Plasmodium vivax, Plasmodium falciparum, and Plasmodium malariae and 10 copies for Plasmodium knowlesi and Plasmodium ovale. LAMP positively detected all human malaria species in all positive samples (N = 134; sensitivity = 100%) within 35 minutes. All negative samples were not amplified by LAMP (N = 67; specificity = 100%). LAMP successfully detected two samples with very low parasitemia. LAMP may offer a rapid, simple, and reliable test for the diagnosis of malaria in areas where malaria is prevalent.
Microscopic examination of thin or thick smears of peripheral blood remains the gold standard for the last 100 years. However, it is well documented in many areas that this method is time consuming and misdiagnosis is common especially in mixed infection and/or when the parasitemia is low. 3 Molecular methods such as conventional polymerase chain reaction (PCR) and real-time PCR may represent a better alternative for malaria diagnosis; however, large-scale application of molecular methods for malaria surveillance has not been implemented, largely due to the high cost of the equipment used.
Loop-mediated isothermal amplification (LAMP) is a rapid and cheap molecular method that enables DNA amplification under isothermal conditions. It is capable in the diagnosis of a wide range of microorganisms associated with bacterial, viral, parasitic, and other diseases in the biomedical field. [4] [5] [6] [7] Several LAMP methods have also been developed for malaria diagnosis based on Plasmodium falciparum histidine-rich protein-2 (PfHRP2), 8 18S rRNA, 9 Plasmodium berghei sporozoite protein with MACPF related domain (PbSPECT2), 10 beta tubulin (β-tubulin), 11 Plasmodium falciparum gametocyte specific genes (Pfs)16 and Pfs25, 12 mitochondrial DNA, 13 and apical membrane antigen 1 (AMA-1).
14 However, up to date, none of the LAMP assays were designed to detect and differentiate all five human malaria parasites (Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium knowlesi, and Plasmodium ovale). In this study, we report the attainment of higher sensitivity of detection of all five human malaria species through the use of LAMP method developed based on Plasmodium small subunit ribosomal RNA (18S rRNA). Results from LAMP were compared with microscopic examination and nested PCR.
Patients, who presented with fever associated with symptoms that doctors on duty considered indicative of a malaria infection (e.g., headache) (N = 181), and healthy donors (N = 20) Plasmodium malaria species were determined by nested PCR targeted at 18S rRNA gene. 15, 16 FIP, BIP, F3, and B3 primers were designed using the Primer-Explorer V3 software (Eiken Chemical Co., Ltd., Tokyo, Japan) based on 18S rRNA gene sequences of P. falciparum, P. vivax, P. malariae, P. knowlesi, and P. ovale (GenBank accession nos. AF145334.1, X13926.1, M54897.1, L07560, and AF145337.1, respectively) ( Table 1) . Loop primers (Loop-F and Loop-B) were designed manually. LAMP was carried out according to the manufacturer's protocol (Loopamp DNA Amplification Kit with Florescent Detection Reagent; Eiken Chemical Co., Ltd.). The amplification was carried out in a Loopamp realtime turbidimeter (LA-320; Teramecs, Co., Ltd., Tochigi, Japan) with reaction mixture, 4 μL DNA template, and speciesspecific primers. All experiments were performed in duplicate at least two times. Several endpoint assessments were carried out to confirm the positive reaction. First, the reaction tube was irradiated with the ultraviolet (UV) light; solutions with amplicons showed stronger green fluorescence under UV compared with the solutions without amplicons. Second, hydroxynaphthol blue dye (HNB) was used for the colorimetric detection of LAMP reaction. 17 A positive reaction was observed by visualizing the color change from violet to sky blue. In addition, PCR was performed on 4 μL LAMP products using F3 and B3 primers. The PCR products were then confirmed by DNA sequencing. 14 For limit of detection, recombinant plasmids encompassing the target region of the 18S rRNA gene were constructed for all five Plasmodium species. The detection limit of LAMP was determined by serially diluted positive control plasmids. The copy number (10 6 copies to one copy) was plotted against the threshold time.
14 Specificity of each species-specific LAMP was examined using genomic DNAs of the other human Plasmodium species and various nonhuman primate Plasmodium species (Plasmodium coatneyi, Plasmodium cynomolgi, Plasmodium The clinical specificity and sensitivity of LAMP 14 were determined based on the results of 201 whole blood samples. A composite diagnosis for each sample (two of three tests giving the same result) was created and used as a reference for all three test modalities. 18 After microscopic analysis, 132 malaria blood samples (30 P. falciparum, 39 P. vivax, one P. malariae, 57 P. knowlesi, one P. ovale, and four mixed infections samples) were identified as positive for malaria infections and 49 samples were found to be negative for malaria infections (Table 2) .
LAMP was found to be optimal with temperature of 65°C for all positive Plasmodium species samples were observed. Amplified products were observed as early as 20 minutes, with a maximal sensitivity reached at 35 minutes. LAMP products were observed either with visual inspection, turbidity reading, or by PCR amplification of the LAMP products. An expected band of ∼200 bp was obtained when the specific LAMP product was used as a template for PCR amplification using B3 and F3 primers, whereas no band was observed from samples containing LAMP product of nonspecific Plasmodium species or negative control.
The detection limit for LAMP was 10 copies for P. knowlesi and P. ovale and one copy for P. vivax, P. malariae, and P. falciparum, respectively. Whereas, nested PCR had a detection limit of 100 copies for P. knowlesi, P. ovale and 10 copies for P. vivax, P. malariae. The high specificity of each LAMP assay was confirmed by using genomic DNA of other human Plasmodium species. Outcomes showed that LAMP was not observed with DNAs of other human Plasmodium species, and cross-reactivity does not occurred between species-specific assays. The analytical specificity of LAMP was also examined by testing genomic DNA of nonhuman malaria species, P. coatneyi, P. cynomolgi, P. fragile, P. brasilianum, and P. inui. No cross-reactivity was observed with DNA from other Plasmodium species, except for P. vivax LAMP. Plasmodium vivax LAMP cross-reactivity with P. cynomolgi and P. fragile predicted as 99% of 18S rRNA gene nucleotide sequence homology was observed using ClustalW2 (http:// www.ebi.ac.uk/Tools/msa/clustalw2/) among the three species.
To evaluate the clinical sensitivity and specificity of LAMP for detection of all five Plasmodium species in human samples, we compared the LAMP method with conventional nested PCR, which target on the 18S rRNA gene, and microscopic examination. Of the 132 samples tested positive with microscopy (parasitemia ranged from 0.01% to 1.52%), all samples were positive with LAMP and 130 samples were positive with nested PCR (Table 2 ). Specificity and sensitivity of LAMP for all five Plasmodium species were 100%, respectively (Table 3) . Under microscopy, P. knowlesi generally resembles P. malariae, and the early stage of P. knowlesi trophozoites resembles those of P. falciparum. Thus, the laboratory misdiagnosis of P. knowlesi is common. 19 In this study, two human patients that were initially diagnosed with either P. knowlesi or P. malariae infection by microscopic examination, presented positive for P. malariae and P. knowlesi, respectively, by LAMP, whereas nested PCR amplification was unable to detect both of these cases because of very low parasitemia (< 0.01%). These results also showed that LAMP could be useful as confirmatory test of malaria infection especially in differentiation of P. malariae or P. knowlesi infection, which could not be easily differentiated under microscope because of morphological similarity.
To our knowledge, this study is the first report of using LAMP for the diagnosis of all the five human malaria species. In this study, Plasmodium species DNA was successfully amplified within 35 minutes for all five malaria parasites (P. falciparum, P. knowlesi, P. vivax, P. malariae, and P. ovale) at 65°C, and the sensitivity of LAMP was 10 times higher compared with nested PCR. All species-specific LAMP assays identified all five human malaria species specifically. In addition, we used HNB dye for the colorimetric detection of the LAMP reaction. The benefit of this LAMP is that the HNB dye allows the test to be interpreted using the naked eye by observing the color change, 20 providing a potential rapid point-of-care method for easy detection of malaria with minimal instrumentation. Combine with the high specificity and sensitivity of LAMP to amplify DNA under isothermal conditions within 35 minutes implies that LAMP may possibly be a good substitute for detection of malaria compared with the nested PCR that requires long operation hour and expensive equipment.
However, there are limitations for LAMP. Because of high sensitivity nature of LAMP, cross-contamination can occur easily. This constraint can be easily overcome by careful pipetting, use of clean bench, and LAMP master mix to avoid frequent exposure of the tube to the environment.
In conclusion, LAMP could be a reliable, convenient, and possible substitute for molecular diagnosis of Plasmodium infection particularly in high malaria transmission regions. Its low cost and high simplicity make it a potentially useful tool for point-of-care diagnosis. However, this LAMP assay needs an initial screening for pan-Plasmodium detection followed by species identification. A composite diagnosis for each sample based on two out of three methods giving the same result was used as reference.
